fashion -WSS

fashion

author：focus 2025-08-26 23:46:27 - browse：1

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： CDC says it’s too soon to assess risk posed by Covid subvariant

WSS

Vivek Ramaswamy made waves in the debate, much as in biotech

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

PBMs are inflating the cost of generic drugs. They must be reined in

Republicans love RFK Jr. What's that tell us about health in 2024?

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Hollywood unions extend contract negotiations for actors

Former Pear Therapeutics executives start new VC firm

Cancer drug shortages should be causing more outrage

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Psychedelics group wrestles with new pharma identity

Beware the threat of staffing cuts at the CDC

DIEP, the 'gold standard' of breast reconstruction, is under threat

Liz Cheney makes 1st public comment since Trump's election interference indictments

BioMarin wins approval for gene therapy to treat hemophilia A

Meadows told special counsel he could not recall Trump ever declassifying Mar

knowledge

ActiGraph execs on goal of drug approvals with digital endpoints

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Vivek Ramaswamy made waves in the debate, much as in biotech

As Maui death toll rises, number of missing remains unclear

Republicans love RFK Jr. What's that tell us about health in 2024?

Baltimore teen accused of firing into crowd during block party mass shooting

focus

entertainment

entertainment

focus